Formulations of suberoylanilide hydroxamic acid and methods for producing same

The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of pr...

Full description

Saved in:
Bibliographic Details
Main Authors MILLER, THOMAS, A, MOSER, JUSTIN, GALLAGHER, KIMBERLY, TUNG, HSIEN-HSIN, STARBUCK, CINDY, COTE, AARON S, DIENEMANN, ERIK, A, COHEN, BENJAMIN MAX, REED, ROBERT A, WONG, JEANNIE CHOW, IKEDA, CRAIG, RAJNIAK, PAVOL, WANG, QINGXI, SELL, BRIAN, CAPODANNO, VINCENT, R
Format Patent
LanguageEnglish
French
German
Published 22.09.2010
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
Bibliography:Application Number: EP20100155706